Victory Capital Management Inc. increased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.9% during the second quarter, Holdings Channel reports. The institutional investor owned 10,769 shares of the company’s stock after buying an additional 91 shares during the period. Victory Capital Management Inc.’s holdings in Thermo Fisher Scientific were worth $1,591,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the company. Commerce Bank raised its stake in shares of Thermo Fisher Scientific by 5.6% in the second quarter. Commerce Bank now owns 195,053 shares of the company’s stock worth $28,821,000 after buying an additional 10,260 shares in the last quarter. Wesbanco Bank Inc. raised its stake in shares of Thermo Fisher Scientific by 17.1% in the second quarter. Wesbanco Bank Inc. now owns 26,463 shares of the company’s stock worth $3,910,000 after buying an additional 3,857 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in shares of Thermo Fisher Scientific by 23.0% in the second quarter. UBS Asset Management Americas Inc. now owns 1,635,244 shares of the company’s stock worth $241,624,000 after buying an additional 305,607 shares in the last quarter. Schroder Investment Management Group raised its stake in shares of Thermo Fisher Scientific by 5.3% in the second quarter. Schroder Investment Management Group now owns 1,679,053 shares of the company’s stock worth $248,097,000 after buying an additional 85,133 shares in the last quarter. Finally, First Pacific Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 5.9% in the second quarter. First Pacific Advisors LLC now owns 1,788,830 shares of the company’s stock worth $264,318,000 after buying an additional 99,770 shares in the last quarter. 87.47% of the stock is owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up 0.26% during midday trading on Monday, hitting $150.44. The company’s stock had a trading volume of 559,413 shares. Thermo Fisher Scientific Inc. has a 12 month low of $117.10 and a 12 month high of $160.68. The firm has a market cap of $59.31 billion, a P/E ratio of 30.09 and a beta of 1.00. The company’s 50 day moving average price is $153.94 and its 200 day moving average price is $148.48.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, July 28th. The company reported $2.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.01 by $0.02. Thermo Fisher Scientific had a net margin of 11.35% and a return on equity of 14.70%. The firm earned $4.54 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the business earned $1.84 earnings per share. The business’s revenue was up 6.2% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc. will post $8.15 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.40%. The ex-dividend date of this dividend is Tuesday, September 13th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 12.02%.

A number of brokerages have commented on TMO. Cleveland Research lowered Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Friday, September 9th. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Jefferies Group reaffirmed a “hold” rating on shares of Thermo Fisher Scientific in a report on Thursday, August 4th. Citigroup Inc. upped their target price on Thermo Fisher Scientific from $160.00 to $182.00 and gave the company a “buy” rating in a report on Friday, July 29th. Finally, Mizuho set a $175.00 target price on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, July 28th. Three research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus target price of $159.66.

In related news, insider Thomas W. Loewald sold 913 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $151.92, for a total transaction of $138,702.96. Following the completion of the sale, the insider now owns 39,983 shares of the company’s stock, valued at $6,074,217.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director C Martin Harris sold 390 shares of the firm’s stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $157.33, for a total transaction of $61,358.70. Following the sale, the director now directly owns 4,648 shares of the company’s stock, valued at approximately $731,269.84. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.